Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial

Added 138 days ago (10.01.2022)
Authors: Gregory W Albers; Rüdiger von Kummer; Thomas Truelsen; Jens-Kristian S Jensen; Gabriela M Ravn; Bjørn A Grønning; Hugues Chabriat; Ku-Chou Chang; Antonio E Davalos; Gary A Ford; James Grotta; Markku Kaste; Lee H Schwamm; Ashfaq Shuaib; DIAS-3 Investigators
Read article